Golden Tiger Pain Relieving Cream Recalled for Out-of-Specification Propylene Glycol
ARG Laboratories is recalling Golden Tiger Natural Pain Relieving Cream nationwide due to use of a violative grade of propylene glycol during manufacturing that renders the active ingredient out of specification.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is a manufacturing defect involving out-of-specification propylene glycol resulting in an out-of-spec active ingredient, which presents a quality-control issue without evidence of actual harm.
Plain-English summary
ARG Laboratories, Inc. is recalling Golden Tiger Natural Pain Relieving Cream due to a manufacturing defect. The product was manufactured using a violative grade of propylene glycol, causing the active ingredient to be out of specification. The affected lot is 01623C1 with an expiration date of 01/31/2025. A total of 3,000 units were distributed nationwide in the United States.
Out-of-specification active ingredients could affect the product's stability or performance. Consumers who have purchased this product should discontinue use immediately. No illnesses or injuries have been reported in connection with this recall. Consumers with questions or health concerns should consult their healthcare provider.
The recalled product
- Product
- NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Tube 4 oz (113.39 g), Mfr. for Golden Tiger USA Albuq, NM, UPC 1 82294 00002 4
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Topical Pain Reliever
- Hazard
- out-of-specification
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 01623C1
- Exp 01/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27